A gene known to cause infant epilepsy is “owned” by a medical company–that’s right a company owns some of the genetic material in a newborn baby’s body. To test a baby for Dravet syndrome, doctors must pay one medical company for the right. “Dr. Deepak Gill . . . said if he could test in-house for the SCNIA gene, which would diagnose the disabling Dravet syndrome, he would test at least 50 per cent more infants.”
